Intravenous Immunoglobulin in the Treatment of Vancomycin-Induced Toxic Epidermal Necrolysis

Sultan Qaboos University Medical Journal

Volumn 13, Issue 1, 2013, Pages 132-136

  El Naggari, Mohamed A ^a   Javad, Hashim ^a   Chacko, Alexander P ^a   Abdelmogheth, Anas A ^a  

^a SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

Author keywords

Case report; Granulocyte colony stimulating factor; Intravenous immunoglobulins; Oman; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

EID: 84875141036     PISSN: 2075051X     EISSN: 20750528     Source Type: Journal    
DOI: 10.12816/0003207     Document Type: Article

References (15)

1. Freiman A, Borsuk D, Sasseville D. Dermatologic emergencies. CMAJ 2005; 22, 173: 1317-19.
2. Del Pozzo-Magana BR, Lazo-Langner A, Carleton B, Castro-Pastrana LI, Rieder MJ. A systematic review of treatment of drug-induced Stevens Johnson syndrome and toxic epidermal necrolysis in children. J Popul Ther Clin Pharmacol 2011; 18:121-33.
3. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129:92-6.
4. Levi N, Bastuji-Garin S, Mockenhaupt M, Roujeau JC, Flahault A, Kelly JP, et al. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: A pooled analysis. Pediatrics 2009; 123:297-303.
5. Lyell A. Toxic epidermal necrolysis: An eruption resembling scalding of the skin. Br J Dermatol 1956; 68:355-61.
6. Al-Raaie F, Banodkar DD. Epidemiological study of cutaneous adverse drug reactions in Oman. Oman Med J 2008; 23:21-7.
7. Becker DS. Toxic epidermal necrolysis. Lancet 1998; 351:1417-20.
8. Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis 2010; 16:5-39.
9. Spies M, Sanford AP, Aili Low JF, Wolf SE, Herndon DN. Treatment of extensive toxic epidermal necrolysis in children. Pediatrics 2001; 108:1162-8.
10. Ofoma UR, Chapnick EK. Fluconazole induced toxic epidermal necrolysis: A case report. Cases J 2009; 20:9071.
11. Cohen S, Billig A, Ad-El D. Ceftriaxone-induced toxic epidermal necrolysis mimicking burn: A case report. J Med Case Rep 2009; 3:9323.
12. Chung WH, Hung SI, Yang JY, Su SC, Huang SP, Wei CY, et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 2008; 14:1343-50.
13. Prendiville JS, Hebert AA, Greenwald MJ, Esterly NB. Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. J Pediatr 1989; 115:881-7.
14. Kayoncu M, Cimsit G, Cakir M, Okten A. Toxic epidermal necrolysis treated with intravenous immunoglobulin and granulocyte colony-stimulating factor. Indian Pediatr 2004; 41:392-5.
15. Al-Mutairi N, Arun J, Osama NE, Amr Z, Mazen AS, Ibtesam el-A, et al. Prospective, noncomparative open study from Kuwait of the role of intravenous immunoglobulin in the treatment of toxic epidermal necrolysis. Int J Dermatol 2004; 43:847-51.